Genitope

Printer-Friendly page

Calendar of Events

Please find below a list of upcoming, and current patient-oriented events featuring Genitope and its investigational product, MyVax® Personalized Immunotherapy (previously referred to as GTOP-99).

UPCOMING EVENTS

 
 Lymphoma Workshop
  Date: September 15, 2007
  Location: Hotel Nikko, San Francisco
  Presented by: Lymphoma Research Foundation

This half-day patient educational workshop brings together leading lymphoma experts to discuss the latest information on lymphoma, its treatments, promising research and clinical trials.

Please visit the LRF website: www.lymphoma.org for more information, or call LRF at (800) 500-9976.

2007 North American Educational Forum on Lymphoma
  Date: Octoberer 12-14, 2007
  Location: Marriott Hotel, Brooklyn, New York
  Presented by: Lymphoma Research Foundation – www.lymphoma.org

Co-sponsored by the Lymphoma Foundation Canada, this annual 2 1/2-day patient educational conference brings together North America’s leading lymphoma experts to discuss the latest information on lymphoma, its treatments, promising research and clinical trials.

Patient support specialists will lead sessions on survivorship and provide information related to coping with the many challenges associated with living with cancer. The Ed Forum offers many opportunities for conference guests to network with fellow patients and caregivers and to discuss their concerns one-on-one with renowned speakers.

Please visit the LRF website: www.lymphoma.org for more information, or call LRF at (800) 500-9976.

CURRENT EVENTS

Educational Webcasts for Patients:
"Testing Vaccines for Non-Hodgkin's Lymphoma"
"Curing Lymphoma: Will a Customized Vaccine Work?"

Lymphoma Research Foundation Webcasts
Date: Currently available
Location: http://lymphomaorg.healthology.com/lymphoma/lymphoma-treatment/dyk3217.htm
Presented By: Lymphoma Research Foundation in partnership with Healthology

Lymphoma experts and vaccine investigators Ron Levy, MD of Stanford University, John Leonard, MD of Weill Medical College, Cornell University, and David Fisher, MD of Dana-Farber Cancer Institute discuss the role personalized immunotherapy (also known as patient-specific vaccine therapy, customized vaccine therapy, or active immunotherapy) may play in the treatment of non-Hodgkin's lymphoma (NHL). Patients will also learn about vaccine therapy clinical trials currently enrolling patients, including a phase 3 trial investigating Genitope's Id-KLH vaccine, MyVax® Personalized Immunotherapy (GTOP-99), in previously untreated follicular NHL.

To view these webcasts, click here: http://lymphomaorg.healthology.com/lymphoma/lymphoma-treatment/dyk3217.htm. For more information on these webcasts, please call LRF at (800) 500-9976 or visit the LRF website at www.lymphoma.org.